Susquehanna International Group’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Susquehanna International Group’s Portfolio RVLP Stock Details RVLP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-58,600	Closed	-$66.8K	–	13556
2023 Q1	$66.8K	Buy	58,600 +800	+1%	+$960	﹤0.01%	11551
2022 Q4	$64.7K	Sell	57,800 -28,300	-33%	-$45.1K	﹤0.01%	11251
2022 Q3	$181K	Buy	86,100 +42,100	+96%	+$81.8K	﹤0.01%	10986
2022 Q2	$60K	Sell	44,000 -3,100	-7%	-$4.49K	﹤0.01%	11870
2022 Q1	$80K	Buy	47,100 +32,100	+214%	+$45.9K	﹤0.01%	12057
2021 Q4	$16K	Buy	+15,000	New	+$24.3K	﹤0.01%	12872

Other funds holding RVLP

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Susquehanna International Group's RVLP Position: Q4 2023 in Review

Susquehanna International Group sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q4 2023, closing a stake of 31,006 shares — an estimated $2.69K sold.

Susquehanna International Group first reported a position in RVLP in Q1 2022 and held it in 5 quarters. The position peaked at $146K in Q1 2023. 3 funds tracked by Wall St. Rank hold RVLP as of Q4 2023.

Susquehanna International Group reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Susquehanna International Group sold 31,006 RVL Pharmaceuticals plc Ordinary Shares shares in Q4 2023, an estimated $2.69K.
Susquehanna International Group first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q1 2022 and held it in 5 quarters.
Susquehanna International Group's RVL Pharmaceuticals plc Ordinary Shares position peaked at $146K in Q1 2023.
3 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q4 2023.

Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.